BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1914365)

  • 1. Mexiletine effects on theophylline disposition.
    Hurwitz A; Vacek JL; Botteron GW; Sztern MI; Hughes EM; Jayaraj A
    Clin Pharmacol Ther; 1991 Sep; 50(3):299-307. PubMed ID: 1914365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of mexiletine on the pharmacokinetics of theophylline in healthy volunteers.
    Stoysich AM; Mohiuddin SM; Destache CJ; Nipper HC; Hilleman DE
    J Clin Pharmacol; 1991 Apr; 31(4):354-7. PubMed ID: 2037708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of interaction between theophylline and mexiletine.
    Ueno K; Miyai K; Kato M; Kawaguchi Y; Suzuki T
    DICP; 1991; 25(7-8):727-30. PubMed ID: 1949927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theophylline metabolism affected by mexiletine.
    Rost KL; Fuhr U; Roots I; Staib AH
    Clin Pharmacol Ther; 1992 Jul; 52(1):107-9. PubMed ID: 1623687
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of theophylline metabolism by mexiletine in young male and female nonsmokers.
    Loi CM; Wei XX; Vestal RE
    Clin Pharmacol Ther; 1991 May; 49(5):571-80. PubMed ID: 2029830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of mexiletine on theophylline pharmacokinetics in patients with bronchial asthma].
    Inafuku M; Suzuki T; Ohtsu F; Hariya Y; Nagasawa K; Yoshioka Y; Nakahara Y; Hayakawa H
    J Cardiol; 1992; 22(1):227-33. PubMed ID: 1284909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of ciprofloxacin on theophylline clearance and steady-state concentrations in serum.
    Schwartz J; Jauregui L; Lettieri J; Bachmann K
    Antimicrob Agents Chemother; 1988 Jan; 32(1):75-7. PubMed ID: 3348614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of mexiletine on elimination and metabolic conversion of theophylline and its major metabolites in rats.
    Ogiso T; Iwaki M; Tanino T; Okuyama K; Uno S
    Biol Pharm Bull; 1993 Feb; 16(2):163-7. PubMed ID: 8364452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steady state pharmacokinetics, metabolism and pharmacodynamics of theophylline in children after unequal twice-daily dosing of a new sustained-release formulation.
    Reinhardt D; Berdel D; Heimann G; Kusenbach G; von Berg A; Johnson E; Steinijans VW; Staudinger H
    Chronobiol Int; 1987; 4(3):369-80. PubMed ID: 3677217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of effect of olanzapine on the pharmacokinetics of a single aminophylline dose in healthy men.
    Macias WL; Bergstrom RF; Cerimele BJ; Kassahun K; Tatum DE; Callaghan JT
    Pharmacotherapy; 1998; 18(6):1237-48. PubMed ID: 9855322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of morning or evening administration on absorption of theophylline.
    Su YM; Cheng TP; Yeh TW; Wen CY; Wang DI
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):113-8. PubMed ID: 10677921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
    González MA; Kisicki J; Straughn AB
    Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between theophylline and mexiletine.
    Ueno K; Miyai K; Seki T; Kawaguchi Y
    DICP; 1990 May; 24(5):471-2. PubMed ID: 1693023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of effect of terfenadine on theophylline pharmacokinetics and metabolism in normal subjects.
    Brion N; Naline E; Beaumont D; Pays M; Advenier C
    Br J Clin Pharmacol; 1989 Mar; 27(3):391-5. PubMed ID: 2497767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the steady-state pharmacokinetics of theophylline during treatment with dirithromycin.
    Bachmann K; Nunlee M; Martin M; Sullivan T; Jauregui L; DeSante K; Sides GD
    J Clin Pharmacol; 1990 Nov; 30(11):1001-5. PubMed ID: 2243147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The theophylline-enoxacin interaction: I. Effect of enoxacin dose size on theophylline disposition.
    Rogge MC; Solomon WR; Sedman AJ; Welling PG; Toothaker RD; Wagner JG
    Clin Pharmacol Ther; 1988 Nov; 44(5):579-87. PubMed ID: 3180639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biopharmaceutic characteristics of a new extended-release theophylline formulation (Uni-Dur).
    Oosterhuis B; Brannan MD; Groen H; Peeters PA; Hempenius J; Radwanski E; Nomeir AA; Affrime MB; Jonkman JH
    Ann Allergy Asthma Immunol; 1995 Aug; 75(2):157-61. PubMed ID: 7648380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative dose study of a theophylline sustained-release tablet formulation after repeated administrations.
    Cova D; Cuglituri G; Rossini L; Bonfardeci G
    Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):273-5. PubMed ID: 2737795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steady-state pharmacokinetics of theophylline in COPD patients treated with dirithromycin.
    Bachmann K; Jauregui L; Sides G; Sullivan TJ
    J Clin Pharmacol; 1993 Sep; 33(9):861-5. PubMed ID: 8227485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal variations in trough serum theophylline concentrations at steady state.
    Lesko LJ; Brousseau D; Canada AT; Eastwood G
    J Pharm Sci; 1980 Mar; 69(3):358-9. PubMed ID: 7381723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.